Lingga, Mary Ann .
HRN: 26-32-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2025
CEFUROXIME 500MG (TAB)
02/04/2025
02/10/2025
ORAL
500mg
2 Times A Day
S/P Repeat CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes